Boutique hotel financing

Are you looking for the best boutique hotel financing? Boutique hotels became popular in the 1980s in major cities such as San Francisco, London, and New York. Boutique hotels differ from the more well-known and larger franchised hotels and motels through its personalizated level of accomodation and services and facilities it has to offer its clients. Themed and stylish, usually with few to several hundred guest rooms, depending on the cities, these hotels are individualized and offer the same guest services, on-site dining facilities, bars, lounges, and cafes open to the public. Boutique hotels are not only unique in appearances in comparison to the norm, but they are also distinct in their financing options.

Since 1977, Ocean Pacific Capital has helped its client find the perfect financing program to meet their capital needs. Property types may vary from full service to limited service, extended stay, resorts, spas, and condo hotel developments. Whether you are looking to build, acquire, reposition (turnaround), or refinance an exisiting boutique hotel, we can help you obtain the boutique hotel financing you need. We also offer bridge, interim, preferred equity, and mezzanine loans. Our access to numerous lenders allows us to offer total loan to value/cost up to 90%, depending on each case, including preferred equity piece or mezzanine. Minimum loan amount starts at $500,000 to $50 million plus. Let our experienced and knowledgeable commercial loan specialists help you obtain the best boutique hotel financing you need to achieve your goal. Contact us at Ocean Pacific Capital today, by calling us toll-free at 1-800-595-1474 or filling our online form.

WSJ.com: US Business

Shell Plans to Drill in Gulf of Mexico Despite Climate and Political Debate
The European oil giant is investing billions of dollars in the Gulf even as the Biden administration sends mixed signals on the future of drilling there.

Rajeev Misra to Step Back From Top Executive Role at SoftBank
Misra, who runs SoftBank?s giant venture-investing arm, plans to run a new outside investment outfit, according to a company memo.

Merck Is in Advanced Talks to Buy Cancer Biotech Seagen
A deal, potentially worth $40 billion or more, would help Merck broaden its lineup of cancer drugs, currently led by Keytruda.

Memory-Chip Prices Fall From Pandemic Highs
The average contract price for a major type of memory fell by 10.6% in the second quarter and prices are expected to decline even more in the coming months.

Senate Report Hits AbbVie's Bermuda Tax Structure for U.S. Humira Sales
Company made most of its overall 2021 sales in the U.S. while recording most of its profits in foreign subsidiaries, leaving it with a tax bill far below the 21% U.S. rate.

Inflation Fears Drove Larger Fed Rate Increase
Fed officials concluded last month they needed to raise rates faster and to levels high enough to slow the economy because of the worsening inflation picture.

Hiring Demand Remained Strong in May
Demand for workers remained robust in late spring, with May job openings and the number of times workers quit their jobs declining but remaining historically high.